-transparent.png){kind=logo}
Two patients with IgA myeloma and one patient with kappa light chain disease developed sideroblastic anaemia from two to four years after the initial diagnosis. All had previously received radiotherapy and chemotherapy (melphalan and prednisone). In two patients the myeloma was quiescent when the sideroblastic change occurred. Leukaemia occurred in two patients two and seven months respectively after the diagnosis of sideroblastic anaemia was made. In one of them, the myeloma became active again at the same time. The development of sideroblastic anaemia may be a pre-leukaemic event and may be recognised by the appearance of a dimorphic blood film.
Related Publications
K P Phadke, and
Y L Kwan, and
S G Young
April 1983,
Lancet (London, England),
K P Phadke, and
Y L Kwan, and
S G Young
January 1977,
Sangre,
K P Phadke, and
Y L Kwan, and
S G Young
September 1974,
British journal of haematology,
K P Phadke, and
Y L Kwan, and
S G Young
December 1994,
Bailliere's clinical haematology,
K P Phadke, and
Y L Kwan, and
S G Young
January 1976,
The New England journal of medicine,
K P Phadke, and
Y L Kwan, and
S G Young
January 1973,
Blood,
K P Phadke, and
Y L Kwan, and
S G Young
March 2009,
Annals of hematology,
K P Phadke, and
Y L Kwan, and
S G Young
February 1969,
The Medical journal of Australia,
K P Phadke, and
Y L Kwan, and
S G Young
January 1965,
British journal of haematology,
